Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13653097 | 0.86 | MAPK14 (0.45) | TOP1HDAC1KMT2AMEN1F10 | |
| SCHEMBL4186723 | 0.83 | TOP1 (0.43) | TOP1RAB9AMAPTSMN1; SMN2NPC1 | |
| SCHEMBL4186731 | 0.83 | TOP1 (0.43) | TOP1RAB9AMAPTSMN1; SMN2NPC1 | |
| SCHEMBL5187630 | 0.80 | KCNK2 (0.49) | TOP1RAB9AMAPTSMN1; SMN2NPC1 | |
| SCHEMBL4187038 | 0.78 | RAB9A (0.39) | TOP1RAB9AMAPTSMN1; SMN2NPC1 | |
| SCHEMBL2829176 | 0.76 | POLB (0.56) | RAB9ANPC1HDAC1KMT2AMEN1 | |
| SCHEMBL12772560 | 0.75 | NPC1 (0.57) | RAB9AMAPTSMN1; SMN2NPC1HDAC1 | |
| SCHEMBL1066788 | 0.75 | F10 (0.53) | RAB9AMAPTNPC1HDAC1KMT2A | |
| SCHEMBL13949629 | 0.75 | MEN1 (0.54) | TOP1RAB9AMAPTNPC1HDAC1 | |
| SCHEMBL3662421 | 0.75 | F10 (0.53) | RAB9AMAPTSMN1; SMN2NPC1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247590-A1 | Indane amides | BAYER PHARMACEUTICLAS CORPORATION (US) | 2009-10-01 | — | — | US | disclosed |
| US-20090247590-A1 | Indane amides | BAYER PHARMACEUTICLAS CORPORATION (US) | 2009-10-01 | — | — | US | disclosed |
| CN-101080389-A | Indane amides with antiproliferative activity | BAYER PHARMACEUTICALS CORP (US) | 2007-11-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247590-A1 | Indane amides | MKI67, PPIP5K2, CCNA1 | TOP1 680/4885RAB9A 4114/4885MAPT 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.